These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 15465626

  • 1. Glycerophosphocholine is elevated in cerebrospinal fluid of Alzheimer patients.
    Walter A, Korth U, Hilgert M, Hartmann J, Weichel O, Hilgert M, Fassbender K, Schmitt A, Klein J.
    Neurobiol Aging; 2004; 25(10):1299-303. PubMed ID: 15465626
    [Abstract] [Full Text] [Related]

  • 2. Differential acetylcholine and choline concentrations in the cerebrospinal fluid of patients with Alzheimer's disease and vascular dementia.
    Jia JP, Jia JM, Zhou WD, Xu M, Chu CB, Yan X, Sun YX.
    Chin Med J (Engl); 2004 Aug; 117(8):1161-4. PubMed ID: 15361288
    [Abstract] [Full Text] [Related]

  • 3. Cerebrospinal fluid from patients with dementia contains increased amounts of an unknown factor.
    White LR, Gårseth M, Aasly J, Sonnewald U.
    J Neurosci Res; 2004 Oct 15; 78(2):297-301. PubMed ID: 15378514
    [Abstract] [Full Text] [Related]

  • 4. Elevated levels of neural recognition molecule L1 in the cerebrospinal fluid of patients with Alzheimer disease and other dementia syndromes.
    Strekalova H, Buhmann C, Kleene R, Eggers C, Saffell J, Hemperly J, Weiller C, Müller-Thomsen T, Schachner M.
    Neurobiol Aging; 2006 Jan 15; 27(1):1-9. PubMed ID: 16298234
    [Abstract] [Full Text] [Related]

  • 5. Erythropoietin in the cerebrospinal fluid in neurodegenerative diseases.
    Brettschneider J, Widl K, Ehrenreich H, Riepe M, Tumani H.
    Neurosci Lett; 2006 Sep 01; 404(3):347-51. PubMed ID: 16815630
    [Abstract] [Full Text] [Related]

  • 6. Elevated interleukin-6 levels in cerebrospinal fluid of vascular dementia patients.
    Wada-Isoe K, Wakutani Y, Urakami K, Nakashima K.
    Acta Neurol Scand; 2004 Aug 01; 110(2):124-7. PubMed ID: 15242421
    [Abstract] [Full Text] [Related]

  • 7. Cerebrospinal fluid tau, Abeta1-42 and inflammatory cytokines in patients with Alzheimer's disease and vascular dementia.
    Jia JP, Meng R, Sun YX, Sun WJ, Ji XM, Jia LF.
    Neurosci Lett; 2004 Aug 01; 383(1-2):12-6. PubMed ID: 15936505
    [Abstract] [Full Text] [Related]

  • 8. Increased intrathecal TGF-beta1, but not IL-12, IFN-gamma and IL-10 levels in Alzheimer's disease patients.
    Rota E, Bellone G, Rocca P, Bergamasco B, Emanuelli G, Ferrero P.
    Neurol Sci; 2006 Apr 01; 27(1):33-9. PubMed ID: 16688597
    [Abstract] [Full Text] [Related]

  • 9. Alpha 1-antichymotrypsin as a possible biochemical marker for Alzheimer-type dementia.
    Matsubara E, Hirai S, Amari M, Shoji M, Yamaguchi H, Okamoto K, Ishiguro K, Harigaya Y, Wakabayashi K.
    Ann Neurol; 1990 Oct 01; 28(4):561-7. PubMed ID: 2147546
    [Abstract] [Full Text] [Related]

  • 10. CSF levels of the histamine metabolite tele-methylhistamine are only slightly decreased in Alzheimer's disease.
    Motawaj M, Peoc'h K, Callebert J, Arrang JM.
    J Alzheimers Dis; 2010 Oct 01; 22(3):861-71. PubMed ID: 20858978
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cerebrospinal fluid levels of free 3-nitrotyrosine are not elevated in the majority of patients with amyotrophic lateral sclerosis or Alzheimer's disease.
    Ryberg H, Söderling AS, Davidsson P, Blennow K, Caidahl K, Persson LI.
    Neurochem Int; 2004 Jul 01; 45(1):57-62. PubMed ID: 15082222
    [Abstract] [Full Text] [Related]

  • 13. Cerebrospinal fluid markers in differential diagnosis of Alzheimer's disease and vascular dementia.
    Boban M, Grbić K, Mladinov M, Hof PR, Süssmair C, Ackl N, Stanić G, Bader B, Danek A, Simić G.
    Coll Antropol; 2008 Jan 01; 32 Suppl 1():31-6. PubMed ID: 18405055
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cerebrospinal fluid acetylcholine, choline, and senile dementia of the Alzheimer's type.
    Davis KL, Hsieh JY, Levy MI, Horvath TB, Davis BM, Mohs RC.
    Psychopharmacol Bull; 1982 Oct 01; 18(4):193-5. PubMed ID: 7156289
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. CSF APPs alpha and phosphorylated tau protein levels in mild cognitive impairment and dementia of Alzheimer's type.
    Fellgiebel A, Kojro E, Müller MJ, Scheurich A, Schmidt LG, Fahrenholz F.
    J Geriatr Psychiatry Neurol; 2009 Mar 01; 22(1):3-9. PubMed ID: 19073834
    [Abstract] [Full Text] [Related]

  • 19. An improved method for assaying phosphocholine and glycerophosphocholine in mouse tissue.
    Murai S, Saito H, Shirato R, Kawaguchi T.
    J Pharmacol Toxicol Methods; 2001 Mar 01; 46(2):103-9. PubMed ID: 12481847
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.